Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BiomX Inc. | 17,600 | reported | 14 Apr 2025 | tx 9+295,050−17,600 |
| Chemomab Therapeutics Ltd. | 6,857 | reported | 16 Mar 2023 | tx 6+56,149 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Apr 2025 | GRANT_AWARD | BiomX Inc. | 17,600 | 0.00 USD | deriv |
| 11 Jul 2024 | GRANT_AWARD | BiomX Inc. | 176,000 | 0.00 USD | deriv |
| 16 Mar 2023 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 6,857 | 0.00 USD | deriv |
| 19 Apr 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 11,884 | 0.00 USD | deriv |
| 07 Mar 2022 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 6,820 | 0.00 USD | deriv |
| 01 Mar 2023 | GRANT_AWARD | BiomX Inc. | 41,000 | 0.00 USD | deriv |
| 29 Mar 2022 | GRANT_AWARD | BiomX Inc. | 20,500 | 0.00 USD | deriv |
| 07 Mar 2022 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 6,820 | 0.00 USD | deriv |
| 19 Apr 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 11,884 | 0.00 USD | deriv |
| 28 Jul 2021 | PURCHASE | BiomX Inc. | 5,000 | 4.00 USD | |
| 28 Jul 2021 | PURCHASE | BiomX Inc. | 3,750 | — | deriv |
| 19 Apr 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 11,884 | 0.00 USD | deriv |
| 30 Mar 2021 | GRANT_AWARD | BiomX Inc. | 15,200 | 0.00 USD | deriv |
| 02 Oct 2020 | GRANT_AWARD | BiomX Inc. | 16,000 | 0.00 USD | deriv |